CollectionsCancer
IN THE NEWS

Cancer

FEATURED ARTICLES
NEWS
July 29, 2009
JIM JOHNSON: 1941-2009
SPORTS
August 17, 2000 | Daily News Wire Services
Jim Marshall, the former Minnesota Vikings star who Tuesday revealed his battle with cancer, told a local television station that it is prostate cancer. He initially had requested that the form of cancer remain confidential. Marshall, 62, said he will go to the Mayo Clinic to consider treatment options.
NEWS
May 4, 2009
RE THE "Beating Cancer" section: It's not going to happen. There is too much money to be made in the business of cancer. Pharmaceutical companies don't want you to be healthy. If you were, they'd be putting themselves out of business. Cancer, like polio and many other ailments, could be cured next month, but at the expense of closing hospitals, getting rid of doctors, closing so-called research hospitals, etc. Pharmaceutical companies seem to almost cure everything, but in reality they don't cure anything - on purpose.
NEWS
July 22, 1986
Claude Lewis' Op-ed Page column of July 7 on drug users being just plain stupid is one of the most realistic assessments of this horrendous, cancer- like problem that is destroying our youth and our nation from within. The bottom line is that only when we as a nation demand the death penalty for drug pushers on the first offense regardless of age or economic status; and only when our elected leaders get up the guts to heed such demands, and only when drug users are held accountable regardless of their station in life, will this cancer begin to be destroyed.
SPORTS
May 13, 1999 | FROM INQUIRER WIRE SERVICES
Houston Astros hitting coach Tom McCraw was diagnosed with prostate cancer the team said yesterday, and he will leave the team at the end of its current homestand on Sunday. McCraw, 58, is in his third season with the Astros and has helped Houston to a National League-best .295 team batting average this year. McCraw learned he might have cancer during a physical exam during spring training. A blood test revealed a high prostate-specific antigen level, which can indicate cancer.
SPORTS
June 24, 1997 | Daily News Wire Services
Less than six months after he sat stunned as Arnold Palmer revealed he had prostate cancer, two-time Senior PGA Tour Player of the Year Jim Colbert had successful surgery yesterday on his cancerous prostate. Colbert, 56, was operated on at Scripps Hospital in La Jolla, Calif., said PGA Tour spokesman David Lancer. "Everything went well and the cancer appears to be localized," said Lancer, who spoke with Colbert's office. Lancer said there is no timetable for Colbert's return to competition.
SPORTS
January 6, 2005 | By Jim Salisbury INQUIRER STAFF WRITER
The mother of Phillies slugger Jim Thome died yesterday afternoon. Joyce Thome, 68, died peacefully at home in Peoria, Ill. She had battled cancer for a year. "She was a wonderful woman," Andrea Thome, Jim's wife, said last night. "She was so much more than a mother-in-law. She was a great friend. We sat at so many games over the years and shared so many laughs. I can't tell you how much she'll be missed. " Doctors diagnosed her with lung cancer last winter, but Mrs. Thome made it to the Phillies' home opener in April.
NEWS
August 20, 1993 | by Ron Avery, Daily News Staff Writer
They'll all be traveling to the Poconos this weekend: 65 volunteer counselors, five nurses and a doctor from the Children's Hospital of Philadelphia and 140 youngsters, age 8 to 18. Some of the kids will be strong and robust. Others will be frail and weak. Some will be bald or missing a limb, or might have a tube in the neck. Eight are blind. They're off for a week of summer camp. What the campers have in common is cancer. Most are in remission. But about 25 percent are still battling for their lives and receiving treatment.
SPORTS
September 5, 2010 | By Rick O'Brien, Inquirer Staff Writer
Waiting for Marco Dapkey was a promise-filled senior football season. His Neshaminy High coaches had selected him to be one of the squad's captains, he was expected to be a two-way contributor for the Redskins, and recruiting interest was growing. All that changed June 13. Struggling with his breathing the night before and into the morning, a panicked Dapkey woke his mother, Rita. That prompted a short trip to Aria Health Bucks County, where physicians, Rita Dapkey said, thought at first that Marco might have a serious sinus infection, or maybe pneumonia.
NEWS
December 12, 1993 | By Pheralyn Dove, INQUIRER CORRESPONDENT
As an actor, Forrest Jones' job is to portray dramatic roles with depth and feeling. But his most demanding role has been in real life - a 15-year ordeal with cancer. Jones, whose cancer has been in remission since 1988, will perform tonight in the opening of Hedgerow Theater's two-hour Christmas production, The Medieval English Mystery Plays, a cycle of nine vignettes. "I never really considered dying. I always figured I would be able to beat it and not have it beat me," Jones, 53, said at the George Washington Carver Community Center here, where he leads a youth drama troupe.
1 | 2 | 3 | 4 | 5 | Next »
ARTICLES BY DATE
NEWS
September 20, 2016
ISSUE | CANCER Increased research funding urgently needed Each of us is just one degree away from cancer. We all know someone who has battled this dreadful disease, and that is why I traveled to Washington last week - to represent cancer survivors and patients in my congressional district. I joined nearly 700 American Cancer Society volunteers from across the country - all decked out in light-blue ACS polo shirts - to urge Congress to increase research funding for the National Cancer Institute by $680 million.
NEWS
September 11, 2016
TOM PRADER was one angry kid. Diagnosed with leukemia at 11, he soon got fed up with sickness, with hospitals, even the people in them. Go to a summer camp for kids with cancer? No way. "I had no interest in doing anything to do with cancer, or being away with people with cancer," he said. Eventually, reluctantly, he agreed to go. "I still resisted at first until the unexplainable magic of camp just happened," Prader said. "People are like you. People understand what you are going through.
NEWS
September 9, 2016 | By Linda Loyd, STAFF WRITER
Merck & Co. said the Food and Drug Administration is reviewing its immunotherapy cancer drug Keytruda as a first-line treatment for patients with advanced lung cancer. The FDA has assigned "priority review" and designated it as a "breakthrough therapy" with a target action date of Dec. 24, the company said. Keytruda, a monoclonal antibody that works by increasing the ability of the body's immune system to help detect and fight tumor cells, is already approved as a second-line treatment for patients who have undergone chemotherapy for advanced non-small-cell lung cancer, and whose condition worsens.
NEWS
September 5, 2016 | By Marie McCullough, Staff Writer
Is removing the prostate through tiny incisions, using a robotic system, better than traditional open-the-abdomen surgery? Prostate cancer specialists have argued about that question for 16 years, ever since U.S. approval of the high-tech, high-cost system made it a coveted commodity for hospitals trying to stay competitive. In July, the Lancet medical journal published an eagerly anticipated Australian clinical trial, the first to randomly assign men to the different methods and compare their outcomes.
NEWS
September 1, 2016 | By Bonnie L. Cook, Staff Writer
Susan V. Kraft, 55, formerly of Coatesville, a retired park ranger and museum curator for the National Park Service, died Tuesday, Aug. 16, of complications from a glioblastoma brain tumor at the Livingston HealthCare Hospital in Livingston, Mont. Ms. Kraft was born in Philadelphia. As a child, she moved with her family to Florida, New Mexico, California, and Bogota, Colombia, then back to Pennsylvania. She graduated from Coatesville Area High School in 1979 and earned a bachelor of arts degree in English from what is now Immaculata University in Malvern.
NEWS
August 29, 2016
Max Ritvo, 25, a poet who chronicled his long battle with cancer in works that were both humorous and searing, died Tuesday at his home in Los Angeles, his mother, Ariella Ritvo-Slifka, said Friday. Mr. Ritvo was diagnosed at 16 with Ewing's sarcoma, a rare cancer that affects bones and soft tissue in children and young adults. Treatment brought about a remission that permitted him to finish high school and attend Yale University, where he performed in an improv comedy group. Mr. Ritvo's cancer returned in his senior year, but he completed Yale and this year earned a master's degree from Columbia University.
NEWS
August 28, 2016 | By Michaelle Bond, Staff Writer
A former Chester County district judge who concealed a harassment citation against her son went to prison Thursday, ending her fight to avoid incarceration while she is under treatment for breast cancer. Rita Jo Ann Arnold, 60, of Downingtown, was sentenced in October 2013 to 16 to 32 months in state prison, more than double the term under state sentencing guidelines. She served six days at the State Correctional Institution in Muncy, Lycoming County, before being released on bail pending appeals.
NEWS
August 25, 2016 | By Bonnie L. Cook, Staff Writer
Quentin M. Giorgio, 64, of Newtown Square, a physician who cared for others despite his own medical issues, died Tuesday, Aug. 9, of peritonitis at the Hospital of the University of Pennsylvania. Dr. Giorgio was diagnosed with testicular cancer at age 21. In the 1970s, cancer treatments were not narrowly targeted as they are now; Dr. Giorgio received aggressive full-body radiation and chemotherapy to combat the cancer, his family said. As a result, he was plagued with complications, especially in the last 10 years, his family said.
BUSINESS
August 24, 2016 | By Linda Loyd, Staff Writer
Pharmaceutical giant Pfizer announced Monday that it will buy cancer biotech company Medivation for about $14 billion, adding a leading prostate-cancer drug to its oncology offerings. San Francisco-based Medivation shares were up nearly 20 percent on the news, closing Monday at $80.42 per share. Pfizer will pay $81.50 a share in cash for Medivation, compared with Sanofi S.A.'s offer in April of $52.50 a share. Since then, Merck, AstraZeneca, Celgene, and Gilead Sciences all reportedly had expressed interest in buying the cancer biotech.
1 | 2 | 3 | 4 | 5 | Next »
|
|
|
|
|